The MEK inhibitors: trametinib and selumetinib cover art

The MEK inhibitors: trametinib and selumetinib

The MEK inhibitors: trametinib and selumetinib

Listen for free

View show details

About this listen

 The MEK inhibitors are a newer class of drug, and include trametinib, selumetinib and others. They have an important role in paediatric oncology, particularly in glioma treatment and in neurofibromatosis.

Hosted on Acast. See acast.com/privacy for more information.

What listeners say about The MEK inhibitors: trametinib and selumetinib

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.